- H1, an NYC-based global platform for the healthcare ecosystem, closed a $58m Series B round of funding
- The round co-led by IVP and Menlo Ventures with participation from Transformation Capital, Lux Capital, Lead Edge Capital, Novartis dRx and YC
- Led by co-founders Ariel Katz and Ian Sax, H1 also connects parties within the healthcare ecosystem
- Then the company has reached growth in 2020
- H1 utilizes data science and intelligence to draw out unique insights and accelerate outcomes for medical affairs, commercial and marketing organizations
- The company counts 13 of the top 20 pharmaceutical companies as its clients
